At Computex 2025, NVIDIA (NVDA) CEO Jensen Huang unveiled a sweeping vision for "physical AI" – a paradigm shift where artificial intelligence transcends digital boundaries to interact with and reshape the physical world. The keynote, delivered before a packed audience in Taipei,…
McDonald’s (MCD) is flipping the script on summer hiring with its most ambitious recruitment drive in years, announcing plans to bring on up to 375,000 new employees across its U.S. restaurants in the coming months-a move as super-sized as its iconic fries.…
In his first network TV interview since becoming Health and Human Services secretary, Robert F. Kennedy Jr. spoke with CBS News chief medical correspondent Dr. Jon LaPook about a range of topics, including measles, food additives, weight loss drugs & their shift…
GeoVax Labs, Inc. (NASDAQ: GOVX), a trailblazer in the biotechnology arena, is steadily carving its niche in the development of vaccines and immunotherapies targeting infectious diseases and cancers. The company recently celebrated a significant milestone: the U.S. Patent and Trademark Office (USPTO)…
Former Treasury Secretary Lawrence Summers has delivered a sobering outlook for the U.S. economy, suggesting that the nation may be teetering on the edge of a recession. With a near 50-50 chance of economic contraction this year, Summers points to a confluence…
Janover Inc. (NASDAQ: JNVR), a South Florida-based AI-powered fintech platform, has reported exceptional financial results for the fourth quarter and full year of 2024 , showcasing its transformative journey in the commercial real estate sector. With a bold pivot toward a subscription-first…
Dollar Tree Decides to Let Go of Family Dollar: A Billion-Dollar Breakup
In a move that's been brewing for a while, Dollar Tree has announced it's selling off its Family Dollar business to Brigade Capital Management and Macellum Capital Management for a…
Jazz Pharmaceuticals' (NASDAQ: JAZZ) $935 million acquisition of Chimerix (NASDAQ: CMRX) marks a significant milestone in precision neuro-oncology, highlighting the growing potential of targeted therapies for brain cancers and signaling a shift towards biomarker-driven approaches in treating central nervous system tumors. The…
Indaptus Therapeutics (NASDAQ: INDP) , a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, has received approval from Health Canada to expand its clinical trial of Decoy20, a promising cancer treatment, into Canada, broadening patient recruitment for its ongoing U.S.-based…
